-
(3S)-morpholin-3-ylmethyl N-[4-({1-[(3-fluorophenyl)methyl]-1H-indazol-5-yl}amino)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl]carbamate
-
ChemBase ID:
162457
-
Molecular Formular:
C27H27FN8O3
-
Molecular Mass:
530.5534832
-
Monoisotopic Mass:
530.21901498
-
SMILES and InChIs
SMILES:
O1CCN[C@@H](C1)COC(=O)Nc1c(c2n(c1)ncnc2Nc1cc2c(cc1)n(nc2)Cc1cccc(c1)F)C
Canonical SMILES:
O=C(Nc1cn2c(c1C)c(ncn2)Nc1ccc2c(c1)cnn2Cc1cccc(c1)F)OC[C@@H]1COCCN1
InChI:
InChI=1S/C27H27FN8O3/c1-17-23(34-27(37)39-15-22-14-38-8-7-29-22)13-36-25(17)26(30-16-32-36)33-21-5-6-24-19(10-21)11-31-35(24)12-18-3-2-4-20(28)9-18/h2-6,9-11,13,16,22,29H,7-8,12,14-15H2,1H3,(H,34,37)(H,30,32,33)/t22-/m0/s1
InChIKey:
LUJZZYWHBDHDQX-QFIPXVFZSA-N
-
Cite this record
CBID:162457 http://www.chembase.cn/molecule-162457.html
NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
IUPAC name
|
(3S)-morpholin-3-ylmethyl N-[4-({1-[(3-fluorophenyl)methyl]-1H-indazol-5-yl}amino)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl]carbamate
|
|
|
IUPAC Traditional name
|
(3S)-morpholin-3-ylmethyl N-[4-({1-[(3-fluorophenyl)methyl]indazol-5-yl}amino)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl]carbamate
|
|
|
Synonyms
|
N-[4-[[1-[(3-Fluorophenyl)methyl]-1H-indazol-5-yl]amino]-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl]carbamic Acid (3S)-3-Morpholinylmethyl Ester
|
AC 480
|
BMS 599626
|
|
|
CAS Number
|
|
PubChem SID
|
|
PubChem CID
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
Data Source
|
Data ID
|
Price
|
TRC
|
|
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
Acid pKa
|
12.238873
|
H Acceptors
|
8
|
H Donor
|
3
|
LogD (pH = 5.5)
|
1.9732387
|
LogD (pH = 7.4)
|
3.6462848
|
Log P
|
3.9929276
|
Molar Refractivity
|
166.6558 cm3
|
Polarizability
|
55.314674 Å3
|
Polar Surface Area
|
119.63 Å2
|
Rotatable Bonds
|
8
|
Lipinski's Rule of Five
|
false
|
PROPERTIES
PROPERTIES
Safety Information
Product Information
Bioassay(PubChem)
DETAILS
DETAILS
TRC
Toronto Research Chemicals -
B596300
|
It is a highly selective and potent inhibitor of HER1 and HER2 kinases and inhibits tumor cell proliferation through modulation of receptor signaling. BMS-599626 inhibits HER1/HER2 receptor heterodimerization and provides an additional mechanism of inhib |
REFERENCES
REFERENCES
From Suppliers
Google Scholar
PubMed
Google Books
- • Wiseman, L., et al.: Eur. J. Cancer, 29A, 2256 (1993)
- • Wittman, M., et al.: J. Med. Chem., 48, 5639 (1993)
- • Allen, G., et al.: Cancer Res., 67, 1155 (1993)
- Searching...Please wait...
PATENTS
PATENTS
PubChem Patent
Google Patent